BENTSUR RON
Insider CIK 1251213 · KERX Chief Executive Officer, Director · STML Director · AITB Director · NVCT Chairman & CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVCT Nuvectis Pharma, Inc. | P Buy | 2026-06-30 | 2026-07-01 | 12,500 | $20.00 | $250.0K | 3,688,424 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2026-01-06 | 2026-01-09 | 150,000 | — | $0 | 3,675,924 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2025-11-05 | 2025-11-06 | 5,000 | $5.72 | $28.6K | 3,525,924 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2025-01-02 | 2025-01-03 | 250,000 | — | $0 | 3,520,924 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2024-12-24 | 2024-12-26 | 4,500 | $4.65 | $20.9K | 3,270,924 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 24,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 25,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 24,000 | — | $0 | 24,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 30,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 40,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 40,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 45,000 | SEC↗ |
| XAIR Beyond Air, Inc. | D To issuer deriv | 2024-11-22 | 2024-11-26 | 45,000 | — | $0 | 0 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2024-11-15 | 2024-11-18 | 20,000 | $4.92 | $98.4K | 3,266,424 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2024-05-14 | 2024-05-15 | 1,940 | $6.74 | $13.1K | 3,246,424 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2024-05-10 | 2024-05-13 | 2,000 | $6.40 | $12.8K | 3,244,484 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2024-03-20 | 2024-03-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2024-03-18 | 2024-03-19 | 5,000 | $10.29 | $51.4K | 3,242,484 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-10-10 | 2023-10-12 | 640 | $11.08 | $7.1K | 3,237,484 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-10-09 | 2023-10-10 | 830 | $11.19 | $9.3K | 3,236,844 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-10-06 | 2023-10-10 | 250 | $11.27 | $2.8K | 3,236,014 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-10-05 | 2023-10-06 | 1,400 | $11.09 | $15.5K | 3,235,764 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-10-04 | 2023-10-06 | 1,820 | $10.95 | $19.9K | 3,234,364 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-08-16 | 2023-08-16 | 115 | $15.15 | $1.7K | 3,232,544 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-08-15 | 2023-08-16 | 235 | $14.34 | $3.4K | 3,232,429 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-08-11 | 2023-08-11 | 180 | $14.66 | $2.6K | 3,232,194 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-08-08 | 2023-08-11 | 120 | $14.83 | $1.8K | 3,232,014 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-21 | 2023-07-24 | 225 | $14.85 | $3.3K | 3,231,894 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-20 | 2023-07-24 | 110 | $15.06 | $1.7K | 3,231,669 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-19 | 2023-07-20 | 200 | $14.33 | $2.9K | 3,231,559 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-14 | 2023-07-18 | 150 | $15.03 | $2.3K | 3,231,359 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-07 | 2023-07-18 | 110 | $16.19 | $1.8K | 3,231,209 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-07-06 | 2023-07-07 | 320 | $14.88 | $4.8K | 3,231,099 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-06-26 | 2023-06-27 | 750 | $16.50 | $12.4K | 3,230,779 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-06-21 | 2023-06-22 | 500 | $17.88 | $8.9K | 3,230,029 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-06-08 | 2023-06-08 | 120 | $17.53 | $2.1K | 3,229,529 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-06-07 | 2023-06-08 | 230 | $17.41 | $4.0K | 3,229,409 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-05-31 | 2023-06-01 | 330 | $17.28 | $5.7K | 3,229,179 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-05-24 | 2023-05-26 | 200 | $17.49 | $3.5K | 3,228,849 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-05-16 | 2023-05-18 | 320 | $17.03 | $5.4K | 3,228,649 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-03-23 | 2023-03-27 | 230 | $12.13 | $2.8K | 3,228,329 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-03-21 | 2023-03-23 | 480 | $12.08 | $5.8K | 3,228,099 | SEC↗ |
| XAIR Beyond Air, Inc. | P Buy | 2023-03-20 | 2023-03-21 | 2,300 | $6.48 | $14.9K | 144,736 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-03-15 | 2023-03-16 | 480 | $10.91 | $5.2K | 3,227,619 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2023-03-14 | 2023-03-16 | 1,680 | $10.85 | $18.2K | 3,227,139 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2023-01-12 | 2023-01-13 | 210,000 | — | $0 | 3,225,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-30 | 2022-11-30 | 150 | $7.45 | $1.1K | 3,015,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-29 | 2022-11-29 | 150 | $7.45 | $1.1K | 3,015,309 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-28 | 2022-11-29 | 150 | $7.40 | $1.1K | 3,015,159 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-25 | 2022-11-29 | 150 | $7.38 | $1.1K | 3,015,009 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-18 | 2022-11-21 | 500 | $7.23 | $3.6K | 3,014,859 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-17 | 2022-11-21 | 250 | $7.24 | $1.8K | 3,014,359 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-11-10 | 2022-11-16 | 1,000 | $7.07 | $7.1K | 3,014,109 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-30 | 2022-10-03 | 500 | $7.46 | $3.7K | 3,013,109 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-28 | 2022-10-03 | 500 | $7.23 | $3.6K | 3,012,609 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-26 | 2022-09-27 | 500 | $7.69 | $3.8K | 3,012,109 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-23 | 2022-09-27 | 1,000 | $7.93 | $7.9K | 3,011,609 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-02 | 2022-09-06 | 1,200 | $8.37 | $10.0K | 3,010,609 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-09-01 | 2022-09-06 | 500 | $8.11 | $4.1K | 3,009,409 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-08-29 | 2022-08-30 | 1,000 | $9.07 | $9.1K | 3,008,909 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-08-23 | 2022-08-30 | 500 | $9.00 | $4.5K | 3,007,909 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-08-19 | 2022-08-22 | 5,000 | $8.99 | $45.0K | 3,007,409 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-08-18 | 2022-08-22 | 14,426 | $8.58 | $123.8K | 3,002,409 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-08-11 | 2022-08-16 | 19,669 | $8.40 | $165.2K | 2,987,983 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2022-06-30 | 2022-07-05 | 40,000 | $6.53 | $261.2K | 142,436 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-06-29 | 2022-06-30 | 3,700 | $11.62 | $43.0K | 2,968,314 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-06-28 | 2022-06-30 | 300 | $11.82 | $3.5K | 2,964,614 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-06-24 | 2022-06-27 | 400 | $12.18 | $4.9K | 2,964,314 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-06-23 | 2022-06-27 | 200 | $11.40 | $2.3K | 2,963,914 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-06-22 | 2022-06-27 | 100 | $13.10 | $1.3K | 2,963,714 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-27 | 2022-05-31 | 500 | $15.74 | $7.9K | 2,963,614 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-26 | 2022-05-31 | 500 | $15.90 | $8.0K | 2,963,114 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-20 | 2022-05-23 | 1,000 | $16.28 | $16.3K | 2,962,614 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-19 | 2022-05-23 | 200 | $18.95 | $3.8K | 2,961,614 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-18 | 2022-05-19 | 1,000 | $18.49 | $18.5K | 2,961,414 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-18 | 2022-05-19 | 700 | $20.60 | $14.4K | 2,960,414 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-17 | 2022-05-19 | 200 | $19.77 | $4.0K | 2,959,604 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-17 | 2022-05-19 | 110 | $20.83 | $2.3K | 2,959,714 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-16 | 2022-05-17 | 1,000 | $19.32 | $19.3K | 2,959,404 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-13 | 2022-05-17 | 700 | $18.10 | $12.7K | 2,958,404 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 1,100 | $14.88 | $16.4K | 2,946,559 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 10,545 | $17.26 | $182.0K | 2,957,704 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-05-12 | 2022-05-13 | 600 | $16.12 | $9.7K | 2,947,159 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | A Award | 2022-04-01 | 2022-04-05 | 120,000 | — | $0 | 2,945,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-03-28 | 2022-03-29 | 4,000 | $7.05 | $28.2K | 2,825,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-03-17 | 2022-03-18 | 7,000 | $7.63 | $53.4K | 2,821,459 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2022-03-03 | 2022-03-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-14 | 2022-02-15 | 8,000 | $5.88 | $47.0K | 2,814,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-10 | 2022-02-11 | 8,500 | $6.34 | $53.9K | 2,806,459 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-07 | 2022-02-08 | 6,000 | $8.25 | $49.5K | 2,797,959 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-07 | 2022-02-08 | 14,000 | $3.93 | $55.0K | 2,791,959 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-04 | 2022-02-08 | 12,500 | $3.89 | $48.6K | 2,777,959 | SEC↗ |
| NVCT Nuvectis Pharma, Inc. | P Buy | 2022-02-04 | 2022-02-08 | 200,000 | $5.00 | $1.00M | 2,765,459 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2021-11-24 | 2021-11-26 | 6,464 | $13.99 | $90.4K | 182,436 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2021-11-24 | 2021-11-26 | 31,000 | $13.44 | $416.6K | 188,900 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise deriv | 2021-11-22 | 2021-11-24 | 50,000 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | F Tax w/h | 2021-11-22 | 2021-11-24 | 12,536 | $14.60 | $183.0K | 219,900 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise | 2021-11-22 | 2021-11-24 | 50,000 | $3.66 | $183.0K | 232,436 | SEC↗ |
| XAIR Beyond Air, Inc. | A Award deriv | 2021-03-04 | 2021-03-08 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise deriv | 2021-02-12 | 2021-02-18 | 23,419 | — | $0 | 0 | SEC↗ |
| XAIR Beyond Air, Inc. | M Exercise | 2021-02-12 | 2021-02-18 | 23,419 | $4.25 | $99.5K | 205,855 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2021-02-12 | 2021-02-18 | 23,419 | $6.36 | $148.9K | 182,436 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2021-02-11 | 2021-02-18 | 1,500 | $6.28 | $9.4K | 182,436 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2021-01-02 | 2021-02-08 | 5,700 | $5.89 | $33.6K | 183,936 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-25 | 2020-08-27 | 1,580 | $5.95 | $9.4K | 189,636 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-24 | 2020-08-25 | 3,889 | $5.68 | $22.1K | 191,216 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-21 | 2020-08-25 | 3,246 | $6.05 | $19.6K | 195,105 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-20 | 2020-08-21 | 3,778 | $6.29 | $23.8K | 198,351 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-19 | 2020-08-21 | 6,533 | $6.32 | $41.3K | 202,129 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-18 | 2020-08-19 | 4,578 | $5.83 | $26.7K | 208,662 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-17 | 2020-08-18 | 4,413 | $5.72 | $25.2K | 213,240 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-14 | 2020-08-17 | 6,680 | $5.53 | $36.9K | 217,653 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-13 | 2020-08-14 | 4,088 | $5.50 | $22.5K | 224,333 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-12 | 2020-08-13 | 4,689 | $5.30 | $24.9K | 228,421 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-11 | 2020-08-12 | 3,910 | $5.51 | $21.5K | 233,110 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-10 | 2020-08-12 | 3,437 | $5.42 | $18.6K | 237,020 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-07 | 2020-08-10 | 10,222 | $5.35 | $54.7K | 245,374 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-06 | 2020-08-07 | 6,192 | $5.94 | $36.8K | 255,596 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-05 | 2020-08-07 | 3,619 | $6.16 | $22.3K | 261,788 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-04 | 2020-08-06 | 3,649 | $6.13 | $22.4K | 265,407 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-08-03 | 2020-08-04 | 3,814 | $6.16 | $23.5K | 269,056 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-07-31 | 2020-08-04 | 2,868 | $6.27 | $18.0K | 272,870 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-07-30 | 2020-07-31 | 3,418 | $6.26 | $21.4K | 275,738 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-07-29 | 2020-07-31 | 1,827 | $6.09 | $11.1K | 279,156 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-07-29 | 2020-07-31 | 2,516 | $6.20 | $15.6K | 280,983 | SEC↗ |
| XAIR Beyond Air, Inc. | S Sale | 2020-07-27 | 2020-08-12 | 4,917 | $6.27 | $30.8K | 278,582 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | D To issuer deriv | 2020-06-10 | 2020-06-10 | 9,034 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | D To issuer deriv | 2020-06-10 | 2020-06-10 | 18,070 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | D To issuer deriv | 2020-06-10 | 2020-06-10 | 24,000 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | D To issuer deriv | 2020-06-10 | 2020-06-10 | 34,000 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | U Tender | 2020-06-10 | 2020-06-10 | 66,346 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2019-06-25 | 2019-06-28 | 15,000 | — | $0 | 55,443 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2019-06-25 | 2019-06-28 | 10,000 | — | $0 | 65,443 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2018-06-21 | 2018-06-22 | 13,158 | — | $0 | 40,443 | SEC↗ |
| AITB AIT Therapeutics, Inc. | P Buy deriv | 2018-02-16 | 2018-05-15 | 23,419 | $0.01 | $234 | 23,419 | SEC↗ |
| AITB AIT Therapeutics, Inc. | P Buy deriv | 2018-02-16 | 2018-05-15 | 23,419 | $0.01 | $234 | 23,419 | SEC↗ |
| AITB AIT Therapeutics, Inc. | M Exercise deriv | 2018-02-16 | 2018-05-15 | 23,419 | — | $0 | 0 | SEC↗ |
| AITB AIT Therapeutics, Inc. | M Exercise | 2018-02-16 | 2018-05-15 | 23,419 | $4.25 | $99.5K | 283,499 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2017-06-19 | 2017-06-20 | 24,000 | — | $0 | 24,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2017-06-19 | 2017-06-20 | 10,000 | — | $0 | 27,285 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2016-05-25 | 2016-05-26 | 34,000 | — | $0 | 34,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award | 2015-06-23 | 2015-06-25 | 10,000 | — | $0 | 17,285 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2015-04-06 | 2015-04-08 | 1,592 | $11.68 | $18.6K | 777,209 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | M Exercise deriv | 2015-03-18 | 2015-03-20 | 5,421 | — | $0 | 0 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | M Exercise | 2015-03-18 | 2015-03-20 | 5,421 | $4.09 | $22.2K | 8,673 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | S Sale | 2015-03-18 | 2015-03-20 | 1,388 | $16.12 | $22.4K | 7,285 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2015-01-05 | 2015-01-06 | 5,574 | $13.79 | $76.9K | 778,801 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2015-01-04 | 2015-01-06 | 134,750 | — | $0 | 134,750 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2015-01-04 | 2015-01-06 | 67,375 | — | $0 | 784,375 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-30 | 2015-01-02 | 200,000 | $14.11 | $2.82M | 717,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-29 | 2014-12-29 | 87,988 | $13.98 | $1.23M | 917,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-26 | 2014-12-29 | 63,500 | $13.98 | $887.7K | 1,004,988 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-24 | 2014-12-29 | 83,000 | $13.98 | $1.16M | 1,068,488 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-12-23 | 2014-12-29 | 104,489 | $13.98 | $1.46M | 1,151,488 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2014-12-22 | 2014-12-23 | 500,000 | — | $0 | 1,255,977 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-10-06 | 2014-10-07 | 68,800 | $15.87 | $1.09M | 755,977 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-10-03 | 2014-10-07 | 2,038 | $16.14 | $32.9K | 824,777 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-09-12 | 2014-09-12 | 50,000 | $14.24 | $712.0K | 826,815 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-07-07 | 2014-07-09 | 1,788 | $15.75 | $28.2K | 876,815 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2014-06-19 | 2014-06-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-04-03 | 2014-04-07 | 1,816 | $16.46 | $29.9K | 878,603 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2014-01-03 | 2014-01-06 | 5,257 | $12.57 | $66.1K | 880,419 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2014-01-02 | 2014-01-06 | 62,092 | — | $0 | 62,092 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2014-01-02 | 2014-01-06 | 26,611 | — | $0 | 885,676 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2013-10-04 | 2013-10-08 | 400,000 | — | $0 | 859,065 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-10-03 | 2013-10-07 | 2,505 | $10.25 | $25.7K | 459,065 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-07-05 | 2013-07-09 | 2,440 | $7.95 | $19.4K | 461,570 | SEC↗ |
| STML STEMLINE THERAPEUTICS INC | A Award deriv | 2013-06-19 | 2013-06-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-04-05 | 2013-04-08 | 1,795 | $6.93 | $12.4K | 464,010 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-03-27 | 2013-03-29 | 31,231 | $6.88 | $214.9K | 465,805 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2013-01-04 | 2013-01-04 | 6,010 | $2.74 | $16.5K | 497,036 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2013-01-02 | 2013-01-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2013-01-02 | 2013-01-04 | 25,000 | — | $0 | 503,046 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-10-03 | 2012-10-05 | 746 | $2.72 | $2.0K | 478,046 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-07-03 | 2012-07-06 | 684 | $1.99 | $1.4K | 478,792 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | P Buy | 2012-04-18 | 2012-04-19 | 3,800 | $1.29 | $4.9K | 479,476 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | P Buy | 2012-04-18 | 2012-04-19 | 15,300 | $1.30 | $19.9K | 475,676 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | P Buy | 2012-04-04 | 2012-04-04 | 71,400 | $1.38 | $98.5K | 460,376 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | S Sale | 2012-01-03 | 2012-01-03 | 3,305 | $2.63 | $8.7K | 388,976 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award deriv | 2012-01-02 | 2012-01-03 | 67,000 | — | $0 | 67,000 | SEC↗ |
| KERX KERYX BIOPHARMACEUTICALS I | A Award | 2012-01-02 | 2012-01-03 | 33,000 | — | $0 | 392,281 | SEC↗ |